Overview
Announcements

Ordinary Rebalance | Solactive Transatlantic Healthcare Equity Index | Effective Date 12th April 2023

In the ordinary rebalance, the following index composition will be implemented effective open 12.04.2023:

ABBOTT LABORATORIES
ABBVIE INC
ALCON INC
AMGEN INC
BAYER AG
BECTON DICKINSON AND CO
BIOGEN INC
BIOMERIEUX
BRISTOL-MYERS SQUIBB CO
CENTENE
COLOPLAST AS CLASS B
ELEVANCE HEALTH INC
ELI LILLY & CO
ENCOMPASS HEALTH CORP
ENSIGN GROUP INC
ESSILORLUXOTTICA
FRESENIUS SE & CO KGAA
GENMAB A/S
GILEAD SCIENCES INC
GSK PLC
HOLOGIC INC
HUMANA INC
INCYTE CORP
JAZZ PHARMACEUTICALS PLC
JOHNSON & JOHNSON
LABORATORY CRP OF AMER HLDGS
MEDTRONIC PLC
MERCK & CO. INC.
MERCK KGAA
MERIT MEDICAL SYSTEMS INC
MOLINA HEALTHCARE INC
NOVARTIS AG
NOVO NORDISK A/S
ORION OYJ CLASS B
PFIZER INC
PRESTIGE CONSUMER HEALTHCARE INC
QIAGEN NV
QUEST DIAGNOSTICS INC
REGENERON PHARMACEUTICALS
RESMED INC
ROCHE HOLDING AG
ROYALTY PHARMA PLC- CL A
SANOFI SA
THE CIGNA GROUP
THERMO FISHER SCIENTIFIC INC
UCB SA
UNITED THERAPEUTICS CORP
UNITEDHEALTH GROUP INC
VERTEX PHARMACEUTICALS INC
ZIMMER BIOMET HOLDINGS INC